No Detail Found!

Short-term Prognostic Value of Tumor Diameter in Stage 2 and 3 Gastric Cancer

Author(s)
Hakan Uzunoglu Department of General Surgery, Kartal Dr Lütfi Kirdar City Hospital, Istanbul, Turkey
Selcuk Kaya Department of General Surgery, Kartal Dr Lütfi Kirdar City Hospital, Istanbul, Turkey
Abstract
Objective: To investigate the prognostic value of tumor diameter in the short term of 3 and 5 years in patients operated for gastric cancer. Study Design: A descriptive study. Place and Duration of Study: Kartal Dr Lüt K1rdar City Hospital, Istanbul, Turkey, from January 2014 to December 2018 Methodology: A total of 125 patients with stage 2 or 3 gastric cancer, followed up in the Department of General Surgery, were included. Demographic information, clinical, laboratory, and pathology reports were analysed in terms of postoperative 30-day mortality. Results: The mean age of the patients was 63.9±11.9 (31-88) years. Forty-four (35.2%) were in stage 2, and 81 (64.8%) were in stage 3 cancers. The mean tumor diameter was 6.5±3.1 cm, and the mean metastatic lymph node rate was 35.6±29.8%. The mean follow-up period was 31.8±21 months. The 3-year and 5-year survival rates were 39.8% and 17.6%, respectively. Tumor diameter was not directly related to survival, di erentiation, number of resected lymph nodes, number of metastatic lymph nodes, and metastatic lymph node rate in stage 2 and 3 cases (p>0.05 for each). The 5-year mortality risk was 1.2-fold higher in those with tumor diameter over 6.5 cm (95% CI 0.7-2.0; p=536). Conclusion: The tumor size did not have a direct e ect on prognosis. It did not provide reliable data about short-term prognosis such as 3 and 5 years in stage 2 and 3 gastric cancer cases.
Publication Details
Page(s) 288-293
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 31, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
Prognosis, gastric cancer, Tumor size, Stage 2, Stage 3
0

Citations

0

Downloads

52

Views